Anti-Zaire Ebolavirus GP protein-Rabbit-scFv, Human-Fc antibody [7H7] (STJA0002887)

Anti-Zaire Ebolavirus GP protein-Rabbit-scFv, Human-Fc antibody [7H7] (STJA0002887)

⇓ Datasheet ⇓ SDS
SPECIFICATIONS
ClonalityMonoclonal
HostRabbit, Human
ConjugationUnconjugated
IsotypehIgG1 scFv Fc
ImmunogenEnvelope glycoprotein processed to GP1 and GP2. Transmembrane and cytoplasmatic domains are removed. Immunogen contains C-terminal linker and hexahistidine tag sequence (GSGHHHHHH). Expressed by 293-based cell line (expressed by QMCF Technology). Ebo
STJA0002887
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit, Human monoclonal anti-Zaire Ebolavirus GP protein-Rabbit-scFv, Human-Fc for use in ELISA, WB and IF in EBOV samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsELISA/WB/IF
HostRabbit, Human
ReactivityEBOV
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone ID7H7
IsotypehIgG1 scFv Fc
ConjugationUnconjugated
PurificationNA Protein A affinity purification
Dilution RangeELISA 25-100 ng/mlWB 0.5-1 ยตg/mlIF 0.156-5 ยตg/ml
FormulationPBS pH 6.0
Storage InstructionStore at-20 to-70ยฐC upon receipt. Divide antibody into aliquots prior usage. Avoid multiple freeze-thaw cycles
Dissociation Constant1.2 x 10-10ย M

Target Information

ImmunogenEnvelope glycoprotein processed to GP1 and GP2. Transmembrane and cytoplasmatic domains are removed. Immunogen contains C-terminal linker and hexahistidine tag sequence (GSGHHHHHH). Expressed by 293-based cell line (expressed by QMCF Technology). Ebo
SpecificityZaire Ebolavirus GP protein

Additional Info

Background GP1 is responsible for binding to the receptors on target cells. Interacts with CD209/DC-SIGN and CLEC4M/DC-SIGNR which act as cofactors for virus entry into the host cell. Binding to CD209 and CLEC4M, which are respectively found on dendritic cells (DCs) , and on endothelial cells of liver sinusoids and lymph node sinuses, facilitate infection of macrophages and endothelial cells. These interactions not only facilitate virus cell entry, but also allow capture of viral particles by DCs and subsequent transmission to susceptible cells without DCs infection (trans infection). GP2 acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.GP1, 2 mediates endothelial cell activation and decreases endothelial barrier function. Mediates activation of primary macrophages. At terminal stages of the viral infection, when its expression is high, GP1, 2 down-modulates the expression of various host cell surface molecules that are essential for immune surveillance and cell adhesion. Down-modulates integrins ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGAV and ITGB1. GP1, 2 alters the cellular recycling of the dimer alpha-V/beta-3 via a dynamin-dependent pathway. Decrease in the host cell surface expression of various adhesion molecules may lead to cell detachment, contributing to the disruption of blood vessel integrity and hemorrhages developed during Ebola virus infection (cytotoxicity). (Ebola GP1 and 2 functions, UniProt).

Information sourced from Uniprot.org

Citations

Product Review

!